Stay updated on AMG 119 in RR SCLC: Safety, Efficacy Clinical Trial
Sign up to get notified when there's something new on the AMG 119 in RR SCLC: Safety, Efficacy Clinical Trial page.

Latest updates to the AMG 119 in RR SCLC: Safety, Efficacy Clinical Trial page
- Check6 days agoChange DetectedAdded the term Small cell lung carcinoma and included a Genetic and Rare Diseases Information Center resource entry.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check21 days agoChange Detected- Page revision label updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check28 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page. This appears to be a minor site version update.SummaryDifference0.1%

- Check56 days agoChange DetectedPage revision updated to Revision: v3.4.2 and the prior funding-status notice about a lapse in government funding (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange DetectedAdded a site-wide notice about government funding and the NIH Clinical Center's open status, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check70 days agoChange DetectedThe page now shows a glossary and introduces new meta-data labels (Last Update Submitted that Met QC Criteria and Last Update Posted). No FEAR Act Data and Revision: v3.4.0 are introduced, replacing the prior No FEAR Act data and Revision: v3.3.4.SummaryDifference0.3%

Stay in the know with updates to AMG 119 in RR SCLC: Safety, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMG 119 in RR SCLC: Safety, Efficacy Clinical Trial page.